Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Thorax. 2017 Jan 12;72(11):971–980. doi: 10.1136/thoraxjnl-2016-208571

Table 3.

The effect of aspirin on bronchoalveolar lavage (BAL) cytokines in healthy volunteers who inhaled lipopolysaccharide

BAL analyte Placebo Aspirin Difference in median (95% CI) p Value
TNFα (pg/mL) 106 (87–154) 78 (52–128) 33 (1.91 to 63.74) 0.03
IL-1β (pg/mL) 43 (26–99) 37 (19–55) 13 (−6 to 46) 0.17
IL-1β:IL-1Ra 0.02 (0.01–0.03) 0.01 (0.008–0.014) 0.01 (−.0.001 to 0.02) 0.07
IL-6 (pg/mL) 857 (606–1263) 648 (330–835) 258 (−40 to 526) 0.07
IL-8 (pg/mL) 448 (321–657) 346 (275–508) 102 (−40 to 253) 0.11
MCP-1 (pg/mL) 547 (412–1055) 502 (348–888) 83 (−168 to 363) 0.45
CRP (pg/mL) 332 (93–1140) 308 (114–824) 9 (−351 to 266) 0.99

IL, interleukin; TNFα, tumour necrosis factor α; MCP, Monocyte chemoattractant protein.